2011Journal of Diseases Monitor & ControlRequires access

studies of fluoxetine and clomipramine in the treatment of patients with obsessive-compulsive disorder

Junxia Li

Open publisher page 0 citations

Abstract

objective To evalute the therapeutic effect and safety of fluoxetine and clomipramine in treatment of obsessive-compulsive disorder.Methods Fifty patients according to CCMD-3 criteria were enrolled in this study.Twenty-five patients taking fluoxetine and another twenty-five patients having domipramine for eight weeks.Symptom improvement and side effects were monitored with clinical evaluation,Yale-Browm OCD rating scale,MSCDPOR, HAMD,HAMA and TESS.Results At the end of eight weeks of treatment,there was no significant difference in the efficacy between fluoxetine and clomipramine.However the side effects of fluoxetine were lighter than clomipramine.Conclusion The results indicate that both fluoxetine and clomipramine is effective in the treatment of OCD,but fluoxetine showed more advantages for its convenient administration and the side effects of it were light.

About this research paper

What this paper is about

objective To evalute the therapeutic effect and safety of fluoxetine and clomipramine in treatment of obsessive-compulsive disorder.Methods Fifty patients according to CCMD-3 criteria were enrolled in this study.Twenty-five patients taking fluoxetine and another twenty-five patients having domipramine for eight weeks.Symptom improvement and side effects were monitored with clinical evaluation,Yale-Browm OCD rating scale,MSCDPOR, HAMD,HAMA and TESS.Results At the end of eight weeks of treatment,there was no significant difference in the efficacy between fluoxetine and clomipramine.However the side effects of fluoxetine were lighter than clomipramine.Conclusion The results indicate that both fluoxetine and clomipramine is effective in the treatment of OCD,but fluoxetine showed more advantages for its convenient administration and the side effects of it were light.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

objective To evalute the therapeutic effect and safety of fluoxetine and clomipramine in treatment of obsessive-compulsive disorder.Methods Fifty patients according to CCMD-3 criteria were enrolled in this study.Twenty-five patients taking fluoxetine and another twenty-five patients having domipramine for eight weeks.Symptom improvement and side effects were monitored with clinical evaluation,Yale-Browm OCD rating scale,MSCDPOR, HAMD,HAMA and TESS.Results At the end of eight weeks of treatment,there was no significant difference in the efficacy between fluoxetine and clomipramine.However the side effects of fluoxetine were lighter than clomipramine.Conclusion The results indicate that both fluoxetine and clomipramine is effective in the treatment of OCD,but fluoxetine showed more advantages for its convenient administration and the side effects of it were light.

Key concepts: Clomipramine, Fluoxetine, Medicine, Hamd, Rating scale, Therapeutic effect, Side effect (computer science), Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
studies of fluoxetine and clomipramine in the treatment of patients with obsessive-compulsive disorder — Research Paper | ScholarLens